Jones Kaylie D, Wheaton Dianna K, Bowne Sara J, Sullivan Lori S, Birch David G, Chen Rui, Daiger Stephen P
Retina Foundation of the Southwest, Dallas, TX.
Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX.
Mol Vis. 2017 Jul 20;23:470-481. eCollection 2017.
With recent availability of next-generation sequencing (NGS), it is becoming more common to pursue disease-targeted panel testing rather than traditional sequential gene-by-gene dideoxy sequencing. In this report, we describe using NGS to identify multiple disease-causing mutations that contribute concurrently or independently to retinal dystrophy in three relatively small families.
Family members underwent comprehensive visual function evaluations, and genetic counseling including a detailed family history. A preliminary genetic inheritance pattern was assigned and updated as additional family members were tested. Family 1 (FAM1) and Family 2 (FAM2) were clinically diagnosed with retinitis pigmentosa (RP) and had a suspected autosomal dominant pedigree with non-penetrance (n.p.). Family 3 (FAM3) consisted of a large family with a diagnosis of RP and an overall dominant pedigree, but the proband had phenotypically cone-rod dystrophy. Initial genetic analysis was performed on one family member with traditional Sanger single gene sequencing and/or panel-based testing, and ultimately, retinal gene-targeted NGS was required to identify the underlying cause of disease for individuals within the three families. Results obtained in these families necessitated further genetic and clinical testing of additional family members to determine the complex genetic and phenotypic etiology of each family.
Genetic testing of FAM1 (n = 4 affected; 1 n.p.) identified a dominant mutation in (p.Arg677Ter) that was present for two of the four affected individuals but absent in the proband and the presumed non-penetrant individual. Retinal gene-targeted NGS in the fourth affected family member revealed compound heterozygous mutations in (p. Cys419Phe, p.Glu767Serfs*21). Genetic testing of FAM2 (n = 3 affected; 1 n.p.) identified three retinal dystrophy genes (, , and ) with disease-causing mutations in varying combinations among the affected family members. Genetic testing of FAM3 (n = 7 affected) identified a mutation in (p.Pro216Leu) tracking with disease in six of the seven affected individuals. Additional retinal gene-targeted NGS testing determined that the proband also harbored a multiple exon deletion in the gene likely accounting for her cone-rod phenotype; her son harbored only the mutation in , not the familial mutation in .
Multiple genes contributing to the retinal dystrophy genotypes within a family were discovered using retinal gene-targeted NGS. Families with noted examples of phenotypic variation or apparent non-penetrant individuals may offer a clue to suspect complex inheritance. Furthermore, this finding underscores that caution should be taken when attributing a single gene disease-causing mutation (or inheritance pattern) to a family as a whole. Identification of a disease-causing mutation in a proband, even with a clear inheritance pattern in hand, may not be sufficient for targeted, known mutation analysis in other family members.
随着新一代测序技术(NGS)的出现,针对疾病的基因panel检测越来越普遍,而不是传统的逐个基因的双脱氧测序。在本报告中,我们描述了使用NGS在三个相对较小的家族中鉴定多个同时或独立导致视网膜营养不良的致病突变。
家庭成员接受了全面的视觉功能评估和包括详细家族史的遗传咨询。初步确定了遗传遗传模式,并在检测更多家庭成员时进行更新。家族1(FAM1)和家族2(FAM2)临床诊断为视网膜色素变性(RP),疑似常染色体显性遗传系谱且存在非外显现象(n.p.)。家族3(FAM3)是一个大家庭,诊断为RP且整体为显性遗传系谱,但先证者表现为锥杆营养不良。最初对一名家庭成员进行了传统的桑格单基因测序和/或基于panel的检测,最终需要进行视网膜基因靶向NGS来确定这三个家族中个体疾病的潜在病因。这些家族获得的结果需要对更多家庭成员进行进一步的遗传和临床检测,以确定每个家族复杂的遗传和表型病因。
对FAM1(n = 4名患者;1名非外显者)的基因检测发现 (p.Arg677Ter)存在显性突变,该突变在4名受影响个体中的2名中出现,但在先证者和假定的非外显个体中不存在。对第四名受影响家庭成员进行的视网膜基因靶向NGS显示 (p.Cys419Phe,p.Glu767Serfs*21)存在复合杂合突变。对FAM2(n = 3名患者;1名非外显者)的基因检测发现三个视网膜营养不良基因(、和)在受影响家庭成员中有不同组合的致病突变。对FAM3(n = 7名患者)的基因检测发现 (p.Pro216Leu)的突变在7名受影响个体中的6名中与疾病相关。额外的视网膜基因靶向NGS检测确定先证者在基因中还存在多个外显子缺失,这可能解释了她的锥杆表型;她的儿子仅携带 中的突变,而非家族性突变。
使用视网膜基因靶向NGS发现了多个导致家族中视网膜营养不良基因型的基因。有明显表型变异或明显非外显个体的家族可能为怀疑复杂遗传提供线索。此外,这一发现强调,在将单一基因致病突变(或遗传模式)归因于整个家族时应谨慎。即使掌握了明确的遗传模式,在先证者中鉴定出致病突变可能也不足以对其他家庭成员进行靶向的已知突变分析。